Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Profile of Ropivacaine after Periarticular Local Infiltration Analgesia for Primary Total Knee Arthroplasty
2014-003010-93Phase 4Completed
- Sponsor
- Sint Maartenskliniek
- Start
- Oct 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ropivacaine in postoperative pain, sponsored by Sint Maartenskliniek. Primary endpoints: Mean total maximum serum concentration of ropivacaine (Cmax) and Mean unbound maximum serum concentration of ropivacaine (Cmax). Started Oct 2014; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2014-003010-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003010-93.